Navigation Links
Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
Date:7/9/2013

evalence of HCV infection is estimated to reach over 13 million people in the United States, EU, and Japan alone, of which only 13% are estimated to be diagnosed and treated.[1] In 2009, the total annual medical costs in the United States for people with hepatitis C are estimated to reach over $30 billion. In the next 20 years, total annual medical costs are expected to increase to approximately $85 billion.[2]

HCV is spread through direct contact with contaminated blood and ultimately leads to serious liver diseases, including liver damage, cirrhosis, liver failure or liver cancer which are all long term consequences of untreated chronic HCV infection.[3] Hepatitis C is the leading cause of liver transplantations in the United States and is reported to contribute to 15,000 deaths annually.[4],[5] With proper treatment, chronic hepatitis C can be cured; however, patients remain at an increased risk for progressive liver disease if they have not achieved complete viral clearance.[6],[7]

About Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. is a publicly-traded, development-stage biopharmaceutical company engaged in the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs in the Unites States, Europe and additional international markets. Sorrento Therapeutics' primary therapeutic focus is oncology but it is also developing therapeutics products for other indications, including inflammation, metabolic, and infectious diseases. Sorrento Therapeutics' proprietary G-MAB® fully-human antibody library platform was designed to facilitate the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. More information is available at <
'/>"/>
SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Awarded Third Phase I STTR Grant
2. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
6. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
7. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
8. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
9. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
11. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Southfield Capital, ... firm, announced today that it completed a ... Communications. BioPharm specializes in the development and multi-channel ... pharmaceutical and biotechnology industries. Through ... shareholders half of their invested capital and ...
(Date:5/4/2015)... BOSTON , May 4, 2015 PAREXEL International ... be presenting at the UBS Healthcare Conference on Monday, May ... Senior Vice President and Chief Financial Officer will be making ... a.m. ET. A live webcast of the presentation ... at www.PAREXEL.com in the Upcoming Events portion of ...
(Date:5/4/2015)... 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ) ... roles, appointing  Donna M. Hughes, as Senior Vice President, ... Senior Vice President, Chief Compliance Officer. Both Ms. Hughes ... Chief Executive Officer, Fred Wilkinson . ... the Impax team," said Fred Wilkinson , President ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2PAREXEL International to Present at UBS Healthcare Conference 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... , , SAN FRANCISCO, Aug. 21 ... first annual "Bridge to Hope," an all-day music festival set to be held ... from 11:00 a.m. to 7:00 p.m. The event will also include an ... selection of gourmet fare from a number of the city,s favorite eateries. , ...
... , , , ... Bay(R) Pharmaceuticals , Inc. (NYSE-Amex: NBY ), a ... prevention of a wide range of bacterial, viral, and fungal infections, ... on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA. ...
Cached Medicine Technology:Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 2Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 3Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 4Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 5NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 2NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 3
(Date:5/4/2015)... 04, 2015 Pricing Healthcare announces ... of one patient receiving care at St. George Surgical ... procedure must be performed by July 15th, 2015, and the ... full up front and forego the filing of insurance claims). ... burdensome every year, and it devastates more and more individuals ...
(Date:5/4/2015)... MT (PRWEB) May 04, 2015 New ... with Care to Care, LLC to manage outpatient advanced ... help New West Medicare ensure its members are provided ... unnecessary radiation. , Working closely with New West Medicare’s ... promoting the safe use of advanced imaging and provide ...
(Date:5/4/2015)... In response to the proposed mammography guidelines from ... Radiology® (SR®) fully aligns itself with organizations such ... the American College Of Surgeons, Susan G. Komen ... College of Radiology (ACR), and Society of Breast ... for women beginning at age 40 in order ...
(Date:5/4/2015)... May 04, 2015 Scanmarket, a leading ... has been included in the just-released Spend Matters “50 ... the Spend Matters " 50 To Know " listing ... of Scanmarket’s commitment to providing comprehensive, easy-to-use strategic sourcing ... Nielsen, “There are many well-established and respected companies on ...
(Date:5/4/2015)... Texas (PRWEB) May 04, 2015 Peacock ... about our mothers. He said, “My mother was the most ... Day, wrap her in lovely, feminine prints and textures ... , Look no further than the Eloise Robe to get ... feel with its cap sleeve and tapered waist. It is ...
Breaking Medicine News(10 mins):Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Scanmarket Selected to Spend Matters "50 To Know" List of Companies in Procurement Sector. 2Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2
... The director of the Planned Parenthood abortion center in ... worked at the clinic for eight years, but departed from ... The Planned Parenthood clinic was the location of the first-ever ... and the prayer and fasting initiative has been held outside ...
... study of various smoking-cessation aids , MONDAY, Nov. 2 ... quit-smoking products finds that a nicotine patch combined with ... than other methods, including antidepressants, this combination best mimics ... smokers kick their habit, experts said. , "The ...
... new study compares neighborhoods, walkability (degree of ease for ... that some neighborhoods might be good for walking, but ... include University of Minnesota faculty member Julian Marshall and ... Frank. The findings highlight the need for urban ...
... between diagnosis and therapy, study finds , MONDAY, Nov. 2 ... to wait between lung cancer diagnosis and treatment is influenced ... study finds. , Researchers at the University of Texas Southwestern ... cell lung cancer. , They found that factors such as ...
... Nov. 2 Cumberland Pharmaceuticals Inc. (Nasdaq: ... care and gastroenterology markets, today announced that Chief Executive Officer ... present an update on the company at the Lazard Healthcare ... Tuesday, November 17, 2009. , The presentation will be ...
... HOUSTON, Nov. 2 Service Corporation International (NYSE: SCI ) announced ... third quarter 2009 on Wednesday, November 4, 2009, after the market closes. ... November 5, 2009. Details of the conference call are as follows: ... International Third Quarter 2009 Earnings, ...
Cached Medicine News:Health News:Planned Parenthood Director Quits Abortion Business, Experiences Conversion at Starting Place of 40 Days for Life 2Health News:Nicotine Patch Plus Lozenge Best for Quitting Smoking 2Health News:Nicotine Patch Plus Lozenge Best for Quitting Smoking 3Health News:Researchers discover links between city walkability and air pollution exposure 2Health News:Researchers discover links between city walkability and air pollution exposure 3Health News:Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call 2
... procedures where stability, access, and precise, ... cantilevered low attenuation carbon fiber tabletop ... radiolucent area is free of cross ... unobstructed C-Arm positioning. Functional design provides ...
...
... Immunoassay Control is a ... designed to complement the ... Immunoassay Plus Controls. This ... to include more complex ...
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: